Document Detail

Comparison of the Effects of Ossein-Hydroxyapatite Complex and Calcium Carbonate on Bone Metabolism in Women with Senile Osteoporosis: A Randomized, Open-Label, Parallel-Group, Controlled, Prospective Study.
MedLine Citation:
PMID:  21946704     Owner:  NLM     Status:  Publisher    
BACKGROUND AND OBJECTIVE: Calcium and vitamin D supplementation is recommended in patients with osteopenia and osteoporosis. One group that could benefit from this treatment is women with senile osteoporosis. Two sources of supplementary calcium are ossein-hydroxyapatite complex (OHC) and calcium carbonate, but, to date, their comparative effects on bone metabolism have not been studied in women with senile osteoporosis. The objective of this study was to compare the effects of OHC and calcium carbonate on bone metabolism in women with senile osteoporosis. METHODS: This was a randomized, open-label, parallel-group, controlled, prospective study to compare the effects of OHC (treatment group) and calcium carbonate (control group) on bone metabolism. Patients were included between 2000 and 2004 and followed up for a maximum of 3 years. The study was carried out at the bone metabolism unit of two university hospitals in Barcelona, Spain. Subjects were women aged >65 years with densitometric osteoporosis of the lumbar spine or femoral neck. The treatment group received open-label OHC (Osteopor) at a dose of two 830 mg tablets every 12 hours (712 mg elemental calcium per day). The control group received open-label calcium carbonate at a dose of 500 mg of elemental calcium every 12 hours (1000 mg elemental calcium per day). Both groups also received a vitamin D supplement (calcifediol 266 μg) at a dose of one vial orally every 15 days. Biochemical markers of bone remodelling (osteocalcin by electrochemiluminescence, tartrate-resistant acid phosphatase using colorimetry) were measured at baseline and annually for 3 years. Bone mineral density (BMD) at the lumbar spine and femoral neck was also measured. RESULTS: One hundred and twenty women were included (55 in the OHC group and 65 in the calcium carbonate group), of whom 54 completed 3 years of follow-up. Levels of serum osteocalcin increased to a greater extent in the OHC group compared with the calcium carbonate group (by a mean ± SD of 0.84 ± 3.13 ng/mL at year 2 and 1.86 ± 2.22 ng/mL at year 3 in the OHC group compared with a mean ± SD decrease of 0.39 ± 1.39 ng/mL at year 2 and an increase of 0.31 ± 2.51 ng/mL at year 3 in the calcium carbonate group); the differences between treatment groups were statistically significant (p < 0.05) at both years. Changes over time in serum osteocalcin level were also statistically significant (p < 0.05) in the OHC group, but not in the calcium carbonate group. Changes in mean BMD at the lumbar spine and femoral neck between baseline and year 3 were -1.1% and 2.5% for OHC and -2.3% and 1.2% for calcium carbonate, respectively. CONCLUSION: OHC had a greater anabolic effect on bone than calcium carbonate.
Manel Ciria-Recasens; Josep Blanch-Rubió; Mónica Coll-Batet; María Del Pilar Lisbona-Pérez; Adolfo Díez-Perez; Jordi Carbonell-Abelló; José Manasanch; Lluís Pérez-Edo
Related Documents :
8696754 - Long-term results of a prospective randomized comparison of total fundic wrap (nissen-r...
12194554 - Adjustable gastric and esophagogastric banding: a randomized clinical trial.
7747374 - Urolume endourethral prosthesis for the treatment of urethral stricture disease: long-t...
19435894 - A multicenter, double-blinded validation study of methylation biomarkers for progressio...
20719364 - Three-dimensional anatomy of the pelvic bone in bladder exstrophy: comparison between p...
24738644 - Weekly risk of venous thromboembolism recurrence in patients receiving oral anticoagula...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-9-22
Journal Detail:
Title:  Clinical drug investigation     Volume:  -     ISSN:  1179-1918     ISO Abbreviation:  -     Publication Date:  2011 Sep 
Date Detail:
Created Date:  2011-9-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9504817     Medline TA:  Clin Drug Investig     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
1Rheumatology Unit, Hospitales Universitarios del Mar y de la Esperança, Barcelona, Spain 2Rheumatology Unit, Hospital de Mataró, Mataró, Barcelona, Spain 3Internal Medicine, Hospital del Mar-IMIM-UAB, Barcelona, and RETICEF, Instituto Carlos III, Madrid, Spain 4Pierre Fabre Ibérica S.A., Barcelona, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Association of imaging markers of myocardial fibrosis with metabolic and functional disturbances in ...
Next Document:  Can body fat distribution, adiponectin levels and inflammation explain differences in insulin resist...